Reply to Yasuma et al
- PMID: 37774400
- PMCID: PMC10868370
- DOI: 10.1164/rccm.202309-1622LE
Reply to Yasuma et al
Figures

Comment on
-
Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension.Am J Respir Crit Care Med. 2023 Dec 1;208(11):1248. doi: 10.1164/rccm.202308-1347LE. Am J Respir Crit Care Med. 2023. PMID: 37774405 Free PMC article. No abstract available.
References
-
- Greig SL, Scott LJ, Plosker GL. Epoprostenol (Veletri®, Caripul®): a review of its use in patients with pulmonary arterial hypertension. Am J Cardiovasc Drugs . 2014;14:463–470. - PubMed
Publication types
Grants and funding
- R00 HL159594/HL/NHLBI NIH HHS/United States
- R21 AI145397/AI/NIAID NIH HHS/United States
- F32 AI143005/AI/NIAID NIH HHS/United States
- R01 AI111820/AI/NIAID NIH HHS/United States
- K99 HL159594/HL/NHLBI NIH HHS/United States
- I01 BX004299/BX/BLRD VA/United States
- U19 AI095227/AI/NIAID NIH HHS/United States
- R01 HL142720/HL/NHLBI NIH HHS/United States
- R01 AI145265/AI/NIAID NIH HHS/United States
- K24 HL155891/HL/NHLBI NIH HHS/United States
- R01 AI124456/AI/NIAID NIH HHS/United States
- T32 HL094296/HL/NHLBI NIH HHS/United States
- I01 BX000624/BX/BLRD VA/United States
LinkOut - more resources
Full Text Sources